Neurobiological Technologies, Inc.
NTII
$0.00
$0.000.00%
OTC PK
| 12/17/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Net Income | 94.11% | 295.69% | 509.79% | 91.49% | -13.87% |
| Total Depreciation and Amortization | -115.00% | -71.43% | -60.78% | -54.90% | -18.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -139.11% | -513.51% | 331.75% | -77.18% | 910.00% |
| Change in Net Operating Assets | 24.55% | -766.07% | -1,060.81% | -122.43% | 7,518.18% |
| Cash from Operations | 148.99% | 178.22% | -3.73% | 28.86% | 2.62% |
| Capital Expenditure | -- | -- | 0.00% | 122.22% | -100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 150.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 213.57% | -185.10% | 116.69% | 24.80% | 20.88% |
| Cash from Investing | 213.48% | -184.07% | 116.73% | 25.65% | 20.87% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5,800.00% | -- | -100.00% | -100.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2,531,700.00% | -- | 100.00% | -100.00% | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 65.08% | 174.38% | 240.04% | 67.48% | -172.82% |